GlassScriptPhysician profile
Richard G Evans
NPI 1003803099
$1,822.40
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $63.62 · 2021: $13.45 · 2022: $69.96 · 2023: $191 · 2024: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $580.95 | 2019-2024 | Arexvy, Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.41 | 2019-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $207.52 | 2019-2024 | Opsumit, Uptravi |
| Sunovion Pharmaceuticals INC. | $156.84 | 2019 | |
| Inspire Medical Systems, INC. | $148.59 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $129.48 | 2019-2024 | Fasenra |
| Novartis Pharmaceuticals Corporation | $91.27 | 2019 | |
| Genzyme Corporation | $57.70 | 2022 | |
| Biofire Diagnostics, LLC | $46.81 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $33.33 | 2019 | |
| Advanced Respiratory, INC | $30.13 | 2019 | |
| Shire North American Group INC | $29.34 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $26.40 | 2024 | Lumryz |
| Genentech USA, INC. | $19.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.50 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.84 | 2019 | |
| Philips North America LLC | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.